1. Diagnosis, treatment and prevention of allergic disease: The basics

Medical Journal of Australia

Volumn 185, Issue 4, 2006, Pages 228-233

  Douglass, Jo A ^a,b   O'Hehir, Robyn E ^a,b  

^a ALFRED HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CYTOKINE ANTIBODY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; INSECT VENOM; INTERLEUKIN 5 ANTIBODY; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ALLERGIC DISEASE; ALLERGIC RHINITIS; ANAMNESIS; ANAPHYLAXIS; ARTICLE; ARTIFICIAL MILK; ASTHMA; B LYMPHOCYTE; BLOOD ANALYSIS; BREAST FEEDING; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFICACY; ENVIRONMENTAL EXPOSURE; FOOD ALLERGY; FOOD INTAKE; HUMAN; IMMUNOTHERAPY; INFLAMMATION; INSECT ALLERGY; PATIENT CARE; PATIENT SELECTION; PRIMARY PREVENTION; RELIABILITY; RISK BENEFIT ANALYSIS; SAFETY; SENSITIZATION; SKIN TEST; SMOKING CESSATION; T LYMPHOCYTE; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

EID: 33748329544     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2006.tb00539.x     Document Type: Article

References (28)

1. Spergel JM. Atopic march: link to upper airways. Curr Opin Allergy Clin Immunol 2005; 5: 17-21.
2. Skin tests used in type I allergy testing. Position paper. Sub-Committee on Skin Tests of the European Academy of Allergology and Clinical Immunology. Allergy 1989; 44 Suppl 10: 1-59.
3. Wood RA, Phipatanakul W, Hamilton RG, Eggleston PA. A comparison of skin prick tests, intradermal skin tests, and RASTs in the diagnosis of cat allergy. J Allergy Clin Immunol 1999; 103 (5 Pt 1): 773-779.
4. National Health and Medical Research Council. How to use the evidence: assessment and application of scientific evidence. Canberra: NHMRC, 2000. http://www.nhmrc.gov.au/publications/_files/cp69.pdf (accessed Jul 2006).
5. Latza U, Haamann F, Baur X. Effectiveness of a nationwide interdisciplinary preventive programme for latex allergy. Int Arch Occup Environ Health 2005; 78: 394-402.
6. Woodcock A, Forster L, Matthews E, et al; Medical Research Council General Practice Research Framework. Control of exposure to mite allergen and allergen-impermeable bed covers for adults with asthma. N Engl J Med 2003; 349: 225-236.
7. Terreehorst I, Hak E, Oosting AJ, et al. Evaluation of impermeable covers for bedding in patients with allergic rhinitis. N Engl J Med 2003; 349: 237-246.
8. Gøtzsche PC, Johansen HK, Schmidt LM, Burr ML. House dust mite control measures for asthma. Cochrane Database Syst Rev 2004; (4): CD001187.
9. Shirai T, Matsui T, Suzuki K, Chida K. Effect of pet removal on pet allergic asthma. Chest 2005; 127: 1565-1571.
10. Gardner LM, Thien FC, Douglass JA, et al. Induction of T "regulatory" cells by standardized house dust mite immunotherapy: an increase in CD4+ CD25+ interleukin-10+ T cells expressing peripheral tissue trafficking markers. Clin Exp Allergy 2004; 34:1209-1219.
11. Westall GP, Thien FCK, Czarny D, et al. Adverse events associated with rush Hymenoptera venom immunotherapy. Med J Aust 2001; 174: 227-230.
12. Moffitt JE, Golden DB, Reisman RE, et al. Stinging insect hypersensitivity: a practice parameter update. J Allergy Clin Immunol 2004; 114: 869-886.
13. Plaut M, Valentine MD. Clinical practice. Allergic rhinitis. N Engl J Med 2005; 353: 1934-1944.
14. Abramson MJ, Puy RM, Weiner JM. Allergen immunotherapy for asthma. Cochrane Database Syst Rev 2003; (4): CD001186.
15. Wilson DR, Lima MT, Durham SR. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 2005; 60: 4-12.
16. Enrique E, Pineda F, Malek T, et al. Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract. J Allergy Clin Immunol 2005; 116: 1073-1079.
17. Prescott SL, Tang MLK. The Australasian Society of Clinical Immunology and Allergy position statement: summary of allergy prevention in children. Med J Aust 2005; 182: 464-467.
18. Chan-Yeung M, Ferguson A, Watson W, et al. The Canadian Childhood Asthma Primary Prevention Study: outcomes at 7 years of age. J Allergy Clin Immunol 2005; 116: 49-55.
19. Peat JK, Mihrshahi S, Kemp AS, et al. Childhood Asthma Prevention Study. Eighteen-month outcomes of house dust mite avoidance and dietary fatty acid modification in the Childhood Asthma Prevention Study (CAPS). J Allergy Clin Immunol 2004; 114: 807-813.
20. Moller C, Dreborg S, Ferdousi HA, et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol 2002; 109: 251-256.
21. Novembre E, Galli E, Landi F, et al. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 2004; 114: 851-857.
22. Warner JO; ETAC Study Group. Early treatment of the atopic child. A double-blinded, randomized, placebo-controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis: 18 months' treatment and 18 months' posttreatment follow-up. J Allergy Clin Immunol 2001; 108: 929-937.
23. Gardner L, O'Hehir RE, Rolland JM. T-cell targeted allergen derivatives for improved efficacy and safety of specific immunotherapy for allergic disease. Curr Med Chem 2003; 2: 351-365.
24. Alexander C, Tarzi M, Larche M, Kay AB. The effect of Fel d 1-derived T-cell peptides on upper and lower airway outcome measurements in cat-allergic subjects. Allergy 2005; 60: 1269-1274.
25. Niebauer K, Dewilde S, Fox-Rushby J, Revicki DA. Impact of omalizumab on quality-of-life outcomes in patients with moderate-to-severe allergic asthma. Ann Allergy Asthma Immunol 2006; 96: 316-326.
26. Leung DY, Sampson HA, Yunginger JW, et al; Avon Longitudinal Study of Parents and Children Study Team. Effect of anti-IgE therapy in patients with peanut allergy. N Engl J Med 2003; 348: 986-993.
27. Flood-Page P, Menzies-Gow A, Phipps S, et al. Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin invest 2003; 112: 1029-1036.
28. Berry MA, Hargadon B, Shelley M, et al. Evidence of a role of tumor necrosis factor alpha in refractory asthma. N Engl J Med 2006; 354: 697-708.